1. Home
  2. ENOV vs AAMI Comparison

ENOV vs AAMI Comparison

Compare ENOV & AAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • AAMI
  • Stock Information
  • Founded
  • ENOV 1995
  • AAMI 1980
  • Country
  • ENOV United States
  • AAMI United States
  • Employees
  • ENOV N/A
  • AAMI N/A
  • Industry
  • ENOV Fluid Controls
  • AAMI Investment Managers
  • Sector
  • ENOV Industrials
  • AAMI Finance
  • Exchange
  • ENOV Nasdaq
  • AAMI Nasdaq
  • Market Cap
  • ENOV 1.8B
  • AAMI 1.6B
  • IPO Year
  • ENOV 2008
  • AAMI N/A
  • Fundamental
  • Price
  • ENOV $31.80
  • AAMI $44.17
  • Analyst Decision
  • ENOV Strong Buy
  • AAMI Hold
  • Analyst Count
  • ENOV 6
  • AAMI 3
  • Target Price
  • ENOV $51.00
  • AAMI $39.67
  • AVG Volume (30 Days)
  • ENOV 809.0K
  • AAMI 285.6K
  • Earning Date
  • ENOV 11-05-2025
  • AAMI 10-30-2025
  • Dividend Yield
  • ENOV N/A
  • AAMI 0.09%
  • EPS Growth
  • ENOV N/A
  • AAMI 43.58
  • EPS
  • ENOV N/A
  • AAMI 2.41
  • Revenue
  • ENOV $2,189,576,000.00
  • AAMI $538,200,000.00
  • Revenue This Year
  • ENOV $9.13
  • AAMI $21.37
  • Revenue Next Year
  • ENOV $6.39
  • AAMI $16.37
  • P/E Ratio
  • ENOV N/A
  • AAMI $18.36
  • Revenue Growth
  • ENOV 14.40
  • AAMI 18.76
  • 52 Week Low
  • ENOV $25.47
  • AAMI $22.60
  • 52 Week High
  • ENOV $49.83
  • AAMI $51.65
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 47.12
  • AAMI N/A
  • Support Level
  • ENOV $30.24
  • AAMI N/A
  • Resistance Level
  • ENOV $32.43
  • AAMI N/A
  • Average True Range (ATR)
  • ENOV 1.00
  • AAMI 0.00
  • MACD
  • ENOV -0.12
  • AAMI 0.00
  • Stochastic Oscillator
  • ENOV 26.45
  • AAMI 0.00

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About AAMI Acadian Asset Management Inc. Common Stock

Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.

Share on Social Networks: